Cargando…
Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination
Atorvastatin and HMG-CoA reductase inhibitors are the most frequently used medication in the world due to very few adverse toxic side effects. One potentially life threatening adverse effect is caused by clinically significant statin induced rhabdomyolysis, either independently or in combination wit...
Autores principales: | Nandy, Anirban, Gaïni, Shahin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222999/ https://www.ncbi.nlm.nih.gov/pubmed/28115938 http://dx.doi.org/10.1155/2016/4705492 |
Ejemplares similares
-
Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature
por: Patoulias, Dimitrios, et al.
Publicado: (2017) -
Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism
por: Ehelepola, N. D. B., et al.
Publicado: (2017) -
Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
por: Banakh, Iouri, et al.
Publicado: (2017) -
Acute-onset rhabdomyolysis secondary to sitagliptin and atorvastatin interaction
por: Khan, Muhammad Waqas, et al.
Publicado: (2016) -
The Concomitant Use of Atorvastatin and Amlodipine Leading to Rhabdomyolysis
por: Khan, Salman, et al.
Publicado: (2018)